PREVIOUS studies in rats have shown that drugs such as ‘Chloretone’, barbital, phenobarbital and amino-pyrine can stimulate the biosynthesis of L-ascorbic acid from glucose through the glucuronic acid pathway1–3 as follows: Evidence for this has come from the observations that these drugs markedly increase the urinary excretion of L-ascorbic acid and that they stimulate the conversion of glucose-1-14C to labelled D-glucuronic acid, L-gulonic acid and L-ascorbic acid3–5. In the present study the following compounds were also found to be potent in stimulating the biosynthesis of L-ascorbic acid: the antirheumatic drug: phenylbutazone, the muscular relaxant: orphenadrine (2-dimethylaminoethyl-2-methyl-benzhydryl ether), and the carcinogenic hydrocarbons: 3-methylcholanthrene, 1,2,5,6-dibenzanthracene and 3,4-benzpyrene. Phenylbutazone and orphenadrine in doses of 20–50 mgm./day for 4 days to adult rats produced about a 20-fold increase in L-ascorbic acid excretion. The striking effect of a single 10-mgm. dose of 3-methylcholanthrene on the urinary excretion of the vitamin is shown in Fig. 1. By 6 days after administration the urinary excretion was 50–75 times greater than the control value and in fact during the 19-day period about 140 mgm. of L-ascorbic acid was excreted. This represents a minimum value for the total L-ascorbic acid synthesized since the vitamin is extensively metabolized in the rat6.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Eisenberg, F., jun., Dayton, P. G., and Burns, J. J., J. Biol. Chem., 234, 250 (1959).
Burns, J. J., Amer. J. Med., 26, 740 (1959).
Burns, J. J., Evans, C., and Trousof, N., J. Biol. Chem., 227, 785 (1957).
Longenecker, H. E., Fricke, H. H., and King, C. G., J. Biol. Chem., 135, 497 (1940).
Horowitz, H. H., and King, C. G., J. Biol. Chem., 200, 125 (1953).
Burns, J. J., Mosbach, E. H., and Schulenberg, S., J. Biol. Chem., 207, 679 (1954).
Conney, A. H., Miller, E. C., and Miller, J. A., Cancer Research, 16, 450 (1956).
Conney, A. H., Miller, E. C., and Miller, J. A., J. Biol. Chem., 228, 753 (1957).
Brodie, B. B., Gillette, J. R., and LaDu, B. N., Ann. Rev. of Biochem., 27, 427 (1958).
About this article
International Archives of Occupational and Environmental Health (1977)
European Journal of Drug Metabolism and Pharmacokinetics (1977)
Evidence for the possible formation of a toxic tyrosine metabolite by the liver microsomal drug metabolizing system
Naunyn-Schmiedeberg's Archives of Pharmacology (1976)